Insomnia in Parkinson’s Disease: Causes, Consequences, and Therapeutic Approaches-Reference-Cited by-同舟云学术

Insomnia in Parkinson’s Disease: Causes, Consequences, and Therapeutic Approaches

Published:2024-08-05 Issue: Volume: Page:
ISSN:0893-7648
Container-title:Molecular Neurobiology
language:en
Short-container-title:Mol Neurobiol

Author:

Duan Xiaoyu,Liu Hanshu,Hu Xinyu,Yu Qinwei,Kuang Guiying,Liu Long,Zhang Shurui,Wang Xinyi,Li Jingwen,Yu Danfang,Huang Jinsha,Wang Tao,Lin Zhicheng,Xiong Nian

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Wuhan medical research project

2019 Wuhan Huanghe Talents Program

Wuhan Science and technology planning project

2022 Outstanding Youth Project of Natural Science Foundation of Hubei province

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12035-024-04400-4.pdf

Reference260 articles.

1. Dorsey ER, Elbaz A, Nichols E et al (2018) Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:939–953. https://doi.org/10.1016/S1474-4422(18)30295-3

2. Pringsheim T, Jette N, Frolkis A, Steeves TDL (2014) The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 29:1583–1590. https://doi.org/10.1002/mds.25945

3. Ou Z, Pan J, Tang S et al (2021) Global trends in the incidence, prevalence, and years lived with disability of Parkinson’s disease in 204 countries/territories from 1990 to 2019. Front Public Health 9:776847. https://doi.org/10.3389/fpubh.2021.776847

4. Zheng Z, Zhu Z, Zhou C et al (2023) Burden of Parkinson disease in China, 1990–2019: findings from the 2019 global burden of disease study. Neuroepidemiology 57:51–64. https://doi.org/10.1159/000527372

5. Willis AW, Roberts E, Beck JC et al (2022) Incidence of Parkinson disease in North America. npj Parkinsons Dis 8:170. https://doi.org/10.1038/s41531-022-00410-y